TCIRG1 (C-Term) Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-TCIRG1 (C-Term) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | TCIRG1 (C-Term) |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | mousepredicted: human |
| Isotype | n/a |
| Format | Protein A purified |
| Size | 0.05 mL, 0.2 mL |
| Concentration | n/a |
| Applications | Flow Cytometry (FC/FACS), Western Blot (WB), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This TCIRG1 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 668-702 amino acids from the human region of human TCIRG1. Part of the proton channel of V-ATPases (By similarity). Seems to be directly involved in T-cell activation. |
| Immunogen | n/a |
| Other Names | [Purified Rabbit (Pab); V-type proton ATPase 116 kDa subunit a isoform 3; V-ATPase 116 kDa isoform a3; Osteoclastic proton pump 116 kDa subunit; OC-116 kDa; OC116; T-cell immune regulator 1; T-cell immune response cDNA7 protein; TIRC7; Vacuolar proton translocating ATPase 116 kDa subunit a isoform 3; TCIRG1; ATP6N1C; ATP6V0A3] |
| Gene, Accession # | [TCIRG1], Gene ID: 10312, NCBI: NP_006010.2, UniProt: Q13488 |
| Catalog # | MBS9231252 |
| Price | $165, $370 |
| Order / More Info | TCIRG1 (C-Term) Antibody from MYBIOSOURCE INC. |
| Product Specific References | Li Y.P.,et al.Biochem. Biophys. Res. Commun. 218:813-821(1996). Utku N.,et al. Submitted (SEP-1997) to the EMBL/GenBank/DDBJ databases. Heinemann T.,et al.Genomics 57:398-406(1999). Mural R.J.,et al. Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. Sobacchi C.,et al.Hum. Mol. Genet. 10:1767-1773(2001). |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies